Covanos, Inc., founded at the Emory University School of Medicine in Atlanta, GA, emerged from a decade-long research collaboration among experts in interventional cardiology and biomechanics. The company’s core mission is to develop next-generation computational solutions for diagnosing and treating cardiovascular diseases. Covanos focuses on leveraging advanced computational technologies to improve the accuracy and efficiency of cardiac and vascular disease diagnosis and treatment.
Notable affiliated individuals include multidisciplinary leaders from Emory University School of Medicine. Covanos has garnered attention for its innovative approach, contributing significantly to the field of cardiovascular healthcare. The company's computational solutions have the potential to transform traditional diagnostic methods, offering more precise and non-invasive alternatives, thereby improving patient outcomes and reducing healthcare costs.